Agilent Technologies Inc. has unveiled a restructuring plan in which it will spin off its Electronic Measurement business (EM) in order to focus on life sciences, diagnostics and applied markets (LDA). EM has a value of approximately $2.9 billion while LDA is valued at approximately $3.9 billion. As part of the move, Agilent has combined its Life Sciences Group with its Diagnostics and Genomics business. Agilent president and chief executive officer William (Bill) Sullivan remarked, “Agilent ha...